2025 North America Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 North America Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America Antimicrobial Susceptibility Testing (AST) market are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation, and bioMérieux SA. BD, Thermo Fisher, and Danaher are U.S.-based firms, contributing significantly to the region's market dominance, driven by their strong portfolios of AST instruments and reagents and extensive healthcare infrastructure support. bioMérieux SA, headquartered in France, also holds a major market share, with recent U.S. FDA approvals for rapid AST systems expanding its influence in North America. These companies lead technological advancements including automated and rapid AST methods essential for combatting drug-resistant infections.
North America commands around 40-46% of the global AST market share due to advanced healthcare systems and high awareness of antimicrobial resistance. These companies play crucial roles in developing and commercializing novel AST technologies, including automation and AI-driven diagnostics that accelerate resistance detection and therapeutic decisions. Their active participation aligns with regional regulatory frameworks promoting antibiotic stewardship and the growing prevalence of multidrug-resistant infections, supporting market expansion. Additional key players in the region include Bio-Rad Laboratories and Accelerate Diagnostics, further strengthening North America's leadership in AST innovation and application.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America Antimicrobial Susceptibility Testing (AST) market are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation, and bioMérieux SA. BD, Thermo Fisher, and Danaher are U.S.-based firms, contributing significantly to the region's market dominance, driven by their strong portfolios of AST instruments and reagents and extensive healthcare infrastructure support. bioMérieux SA, headquartered in France, also holds a major market share, with recent U.S. FDA approvals for rapid AST systems expanding its influence in North America. These companies lead technological advancements including automated and rapid AST methods essential for combatting drug-resistant infections.
North America commands around 40-46% of the global AST market share due to advanced healthcare systems and high awareness of antimicrobial resistance. These companies play crucial roles in developing and commercializing novel AST technologies, including automation and AI-driven diagnostics that accelerate resistance detection and therapeutic decisions. Their active participation aligns with regional regulatory frameworks promoting antibiotic stewardship and the growing prevalence of multidrug-resistant infections, supporting market expansion. Additional key players in the region include Bio-Rad Laboratories and Accelerate Diagnostics, further strengthening North America's leadership in AST innovation and application.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
